日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

撤稿声明:利福昔明会改变肠道菌群组成,但不会影响全身炎症——一项针对常见变异型免疫缺陷的随机对照试验

Jørgensen, S F; Macpherson, M E; Bjørnetrø, T; Holm, K; Kummen, M; Rashidi, A; Michelsen, A E; Lekva, T; Halvorsen, B; Trøseid, M; Mollnes, T E; Berge, R K; Yndestad, A; Ueland, T; Karlsen, T H; Aukrust, P; Hov, J R; Fevang, B

Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation

趋化因子与常见变异型免疫缺陷;CCL19、CCL21 和 CCR7 对免疫失调的可能作用

Fevang, B; Yndestad, A; Damås, J K; Halvorsen, B; Holm, A M; Beiske, K; Aukrust, P; Frøland, S S

Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia.

常见变异型免疫缺陷中大颗粒淋巴细胞的多克隆扩增——与中性粒细胞减少症相关

Holm A M, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland S S

Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro

韦格纳肉芽肿患者体内趋化因子表达增加——甲基强的松龙体外调节作用

Torheim, E A; Yndestad, A; Bjerkeli, V; Halvorsen, B; Aukrust, P; Frøland, S S

Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.

HIV感染患者单核细胞中Toll样受体2的刺激可诱导趋化因子反应:可能产生致病后果

Heggelund L, Damås J K, Yndestad A, Holm A M, Mūller F, Lien E, Espevik T, Aukrust P, Frøland S S

Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients.

血清中白细胞介素-18 水平升高与疾病进展相关,并可能导致 HIV-1 感染患者的病毒学治疗失败

Stylianou E, Bjerkeli V, Yndestad A, Heggelund L, Waehre T, Damås J K, Aukrust P, Frøland S S